Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px

Document › Details

CRISPR Therapeutics AG. (2/12/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results". Zug & Cambridge, MA.

	Organisation	CRISPR Therapeutics AG (Nasdaq: CRSP)
	Group	CRISPR Therapeutics (Group)
	Organisation 2	Vertex Pharmaceuticals Inc. (Nasdaq: VRTX)
	Group	Vertex Pharmaceuticals (Group)
	Product	CTX001 (CRISPR Therapeutics/Vertex)
	Product 2	CTX110 allogeneic CAR-T cell therapy
	Person	Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO)
	Person 2	Kim, Susan (CRISPR Therapeutics 201809 Investor Relations)

Original document
accessed by [iito] on 2020-02-26

Record changed: 2020-03-02

Picture [iito] Made Without Love 650x80px

More documents for CRISPR Therapeutics (Group)

[1] CRISPR Therapeutics AG. (5/6/21). "Press Release: CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer". Zug, Cambridge, MA & South San Francisco, CA....
[2] CRISPR Therapeutics AG. (2/1/21). "Press Release: CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer". Zug & Cambridge, MA....
[3] CRISPR Therapeutics AG. (10/28/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results". Zug & Cambridge, MA....
[4] CRISPR Therapeutics AG. (6/30/20). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA....
[5] CRISPR Therapeutics AG. (6/29/20). "Press Release: CRISPR Therapeutics Announces Proposed Offering of Common Shares". Zug & Cambridge, MA....
[6] CRISPR Therapeutics AG. (6/25/20). "Press Release: CRISPR Therapeutics Announces the Build-Out of New Cell Therapy Manufacturing Facility". Zug & Cambridge, MA....
[7] CRISPR Therapeutics AG. (5/11/20). "Press Release: CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001 for the Treatment of Severe Hemoglobinopathies". Zug, Cambridge, MA...
[8] CRISPR Therapeutics AG. (5/7/20). "Press Release: CRISPR Therapeutics to Present at the Bank of America Securities 2020 Health Care Conference". Zug & Cambridge, MA....
[9] CRISPR Therapeutics AG. (2/26/20). "Press Release: CRISPR Therapeutics Proposes Changes to the Board of Directors". Zug & Cambridge, MA....
[10] CRISPR Therapeutics AG. (11/20/19). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]